Drug utilization data as a vehicle to enhance regulatory dialogue
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Presentation
- By: TORRE, Carla (Centre for Health Evaluation & Research (ANF Group), Lisboa, Portugal)
Drug utilization studies describe how a medicinal product is marketed, prescribed and used in a population, and how these factors influence outcomes, including clinical, social and economic outcomes. Therapeutic practice is expected to be primarily based on evidence provided by pre marketed clinical trials, but complementary data from.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.